Lundbeckfond Invest A/S 4
4 · IO Biotech, Inc. · Filed Aug 11, 2023
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Lundbeckfond Invest A/S
Director10% Owner
Transactions
- Award
Common Stock
2023-08-09$1.90/sh+7,901,234$15,012,345→ 13,950,686 total - Award
Warrants (Right to Buy)
[F1]2023-08-09$0.13/sh+7,901,234$987,654→ 7,901,234 totalExercise: $2.47From: 2023-08-09→ Common Stock (7,901,234 underlying)
Footnotes (1)
- [F1]These warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition (as such term is defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023).
Signature
Lundbeckfond Invest A/S, by: /s/ Brian Burkavage, Attorney-in-Fact for Christian Elling, Managing Partner, and Lene Skole, Chief Executive Officer|2023-08-11